Michael S. Sitrick serves as Executive at Abraxis BioScience, Inc., where they oversee executive responsibilities. Since joining the company, Michael S. Sitrick has executed 12 insider transactions totaling $271.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 9, 2019 involved selling 13,676 shares valued at $25.0K.
Michael S. Sitrick currently holds 228,951 shares of Abraxis BioScience, Inc. (ABBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael S. Sitrick has been a net buyer of ABBI stock. They have purchased $271.3K and sold $0 worth of shares.
Michael S. Sitrick's most recent insider trade was on Aug 9, 2019, when they sold 13,676 shares at $1.83 per share.
Get notified when new Form 4 filings are submitted
| 13,676 |
| $1.83 |
| Discretionary |
| Jan 1, 2019 | JAKK | $100.1K | Award | 54,705 | $1.83 | Discretionary |
| Sep 6, 2018 | NH | $0 | Award | 45,002 | $N/A | Discretionary |
| Sep 6, 2018 | NH | $0 | Award | 52,910 | $N/A | Discretionary |
| Jan 1, 2018 | JAKK | $100.2K | Award | 41,580 | $2.41 | Discretionary |
| Nov 6, 2017 | NH | $0 | Award | 50,868 | $N/A | Discretionary |
| Aug 7, 2017 | JAKK | $35.0K | Purchase | 10,000 | $3.50 | Discretionary |
| Jan 1, 2017 | JAKK | $99.9K | Award | 19,324 | $5.17 | Discretionary |
| Feb 26, 2016 | JAKK | $236.3K | Purchase | 35,000 | $6.75 | Discretionary |
| Jan 1, 2016 | JAKK | $100.0K | Award | 12,542 | $7.97 | Discretionary |
| Aug 1, 2006 | ABBI | $150.5K | Award | 7,500 | $20.07 | Discretionary |